News Agencies Feed 

HEALTHCARE

Saudi child paid Dh500,000 damages for Aids infection
May 28, 2015

A Saudi court ordered a hospital to pay Dh500,000 damages to a little girl who was infected with the deadly Aids disease after she was given contaminated blood by mistake, a newspaper in the Gulf Kingdom reported on Thursday.

A panel of judges in the Southern Jazan province decided on the compensation after several court hearings that began a few months after Riham Al Hikmi fell ill in mid 2013.

“The court closed the case by ordering the hospital to pay SR500,000 (Dh500,000) to the girl…the case has led...

Continue Reading >

Type 2 diabetes: Synjardy® (empagliflozin/metformin hydrochloride) approved in the European Union
May 28, 2015

  • Marketing authorisation granted for new single-pill combination shown to lower blood glucose
  • Synjardy® combines two products with different mechanisms of action to improve glycaemic control in patients with T2D
  • Side effects identified with Synjardy® are consistent with known safety profiles of the individual compounds

Synjardy® has been granted marketing authorisation by the European Commission for the treatment of adults"...

Continue Reading >

H.E Mr. Abdulla bin Khalid Al-Qahtani, Minister of Public Health & Secretary General of the Supreme Council of Health (SCH) inaugurates
May 27, 2015

The Qatar International Medical Congress (QIMC) 2015


Under the patronage of the Prime Minister of Qatar and Minister of Interior, HE Sheikh Abdullah bin Nasser bin Khalifa Al Thani .. H.E Mr. Abdulla bin Khalid Al-Qahtani, Minister of Public Health & Secretary General of the Supreme Council of Health (SCH)"...

Continue Reading >

Jawaher Al Qasimi Helps Save Lives of 30,000 Kids Yearly Through Cancer Fund
May 27, 2015

An International Childhood Cancer Fund (ChiCa) has been launched by Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of His Highness the Ruler of Sharjah, Founder and Royal Patron of the Friends of Cancer Patients Society (FoCP), the International Ambassador of the World Cancer Declaration for Union for International Cancer Control (UICC), and International Ambassador for Childhood Cancer for UICC.


...

Continue Reading >

Sanofi KSA teams up with SPA to stimulate health of children
May 25, 2015

In collaboration with Saudi Pediatric Association (SPA) , Sanofi KSA has launched its pediatric initiative to promote health for children. Under the slogan of “Happy Children, Healthy Children”, Sanofi aims to widen the scope of its healthcare offerings to Saudi young patients with innovative products and services in addition to periodic launch of awareness initiatives dedicated to children, parents, healthcare professionals and public authorities.

The core objective of the initiative is to provide a clear picture...

Continue Reading >

TIELLE® Non Adhesive Foam Dressing Now Available from Acelity
May 19, 2015

Acelity, a global wound care and regenerative medicine company, today announced that TIELLE® Non Adhesive, a new and improved foam dressing, is now available in Europe. TIELLE® Non Adhesive is the first in an enhanced range of TIELLE® hydropolymer foam dressings incorporating new design and materials to better meet patient needs and help provide a comfortable and effective healing environment for all types of wounds.


The"......

Continue Reading >

Analysis of Phase II Data for Celgene’s Investigational Oral GED-0301 in Patients with Active Crohn’s Disease Presented at Digestive Disease Week
May 19, 2015

Celgene Corporation (NASDAQ: CELG) today announced that a post-hoc subgroup analysis of a double-blind, placebo-controlled, randomized, multicenter phase II trial of GED-0301 (mongersen) in patients with active Crohn's disease was presented at Digestive Disease Week (DDW) in Washington, D.C.


“For patients"...

Continue Reading >

Philips unveils latest healthcare innovations to uplift patient care
May 18, 2015

PHILIPS Healthcare Saudi Arabia Ltd. is showcasing healthcare innovations and solutions at the Saudi Health 2015 that opens today in Riyadh in support the government’s goal to strengthen healthcare infrastructure and develop a world class healthcare system in the Kingdom.

As a company committed to improve 3 billion lives a year by 2025, Philips is proud to showcase its technologies that will support Saudi families across the health continuum of care from healthy living and prevention, to diagnosis, treatment, recovery and...

Continue Reading >

Boehringer Ingelheim acquires Pharmaxis’ phase 1 anti-inflammatory drug candidate
May 18, 2015

  • Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis’ investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights.
  • PXS4728A is a highly selective oral small molecule inhibitor of vascular adhesion protein-1 that has shown activity in pre-clinical investigation in non-alcoholic steatohepatitis (NASH).
  • Drug candidate will be investigated for the treatment of NASH and has further potential in chronic obstructive pulmonary disease...

    Continue Reading >

New data and analyses confirm the efficacy and safety of OFEV® (nintedanib*) for the treatment of IPF beyond 52 weeks and for distinct subgroups
May 18, 2015

  • Effect of nintedanib* on slowing disease progression was maintained for up to 76 weeks in the TOMORROW trial
  • Long-term nintedanib* treatment in the INPULSIS®-ON extension study confirms manageable safety and tolerability profile for up to 33 months
  • Pooled analyses confirm efficacy of nintedanib* in patients with early IPF disease (forced vital capacity (FVC) > 90% predicted at baseline)
  • Nintedanib* is the first targeted treatment for IPF to consistently demonstrate its efficacy in two identically...

    Continue Reading >